Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline M Tanner

Showing results (61-70 of 207) with videos related to

Pageof 21
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2024
Parkinson's Disease Progression and Exposure to Contaminated Water at Camp LejeuneSamuel M Goldman, Frances M Weaver, Beverly Gonzalez, et al.
Frontiers in Neurology|November 7, 2022
Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaRajesh Pahwa, Susan Fox, Robert A Hauser, et al.
JAMA Neurology|May 15, 2023
Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp LejeuneSamuel M Goldman, Frances M Weaver, Kevin T Stroupe, et al.
American Journal of Epidemiology|June 5, 2003
Incidence of Parkinson's disease: variation by age, gender, and race/ethnicityStephen K Van Den Eeden, Caroline M Tanner, Allan L Bernstein, et al.
Scientific Reports|July 11, 2020
Electrocardiographic changes predate Parkinson's disease onsetOguz Akbilgic, Rishikesan Kamaleswaran, Akram Mohammed, et al.
Journal of Parkinson'S Disease|January 14, 2020
EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's DiseaseCaroline M Tanner, Rajesh Pahwa, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2008
Bowel movement frequency in late-life and substantia nigra neuron density at deathHelen Petrovitch, Robert D Abbott, G Webster Ross, et al.
Movement Disorders Clinical Practice|May 22, 2018
Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open-label ADS-5102Stuart H Isaacson, Stanley Fahn, Rajesh Pahwa, et al.
Journal of Patient-Reported Outcomes|March 9, 2023
Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT studyCaroline M Tanner, Stanley N Caroff, Andrew J Cutler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 4, 2024
Validation of Parkinson's Disease Ascertainment in the Veterans Administration Electronic Medical RecordSamuel M Goldman, Frances M Weaver, Lishan Cao, et al.
Pageof 21

Showing results (61-70 of 207) with videos related to

Sort By:
Pageof 21
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2024
Parkinson's Disease Progression and Exposure to Contaminated Water at Camp LejeuneSamuel M Goldman, Frances M Weaver, Beverly Gonzalez, et al.
Frontiers in Neurology|November 7, 2022
Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaRajesh Pahwa, Susan Fox, Robert A Hauser, et al.
JAMA Neurology|May 15, 2023
Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp LejeuneSamuel M Goldman, Frances M Weaver, Kevin T Stroupe, et al.
American Journal of Epidemiology|June 5, 2003
Incidence of Parkinson's disease: variation by age, gender, and race/ethnicityStephen K Van Den Eeden, Caroline M Tanner, Allan L Bernstein, et al.
Scientific Reports|July 11, 2020
Electrocardiographic changes predate Parkinson's disease onsetOguz Akbilgic, Rishikesan Kamaleswaran, Akram Mohammed, et al.
Journal of Parkinson'S Disease|January 14, 2020
EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's DiseaseCaroline M Tanner, Rajesh Pahwa, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2008
Bowel movement frequency in late-life and substantia nigra neuron density at deathHelen Petrovitch, Robert D Abbott, G Webster Ross, et al.
Movement Disorders Clinical Practice|May 22, 2018
Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open-label ADS-5102Stuart H Isaacson, Stanley Fahn, Rajesh Pahwa, et al.
Journal of Patient-Reported Outcomes|March 9, 2023
Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT studyCaroline M Tanner, Stanley N Caroff, Andrew J Cutler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 4, 2024
Validation of Parkinson's Disease Ascertainment in the Veterans Administration Electronic Medical RecordSamuel M Goldman, Frances M Weaver, Lishan Cao, et al.
Pageof 21